查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375859

心臟生物標記市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2023-2030 年

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP And NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

心臟生物標記市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2023年至2030年全球心臟生物標記市場規模將以14.6%的年複合成長率成長，2030年達到478.8億美元。

急性冠狀動脈症候群綜合症（ACS）盛行率的增加以及生物標記技術的進步預計將推動市場成長。對心臟疾病早期診斷和預後的認知不斷提高預計將進一步推動市場。

根據NCBI預測，2021年美國將有超過1,550萬人罹患心臟疾病。胸痛是急診就診最常見的原因之一。心臟病是美國的主要原因之一，估計每 41 秒就有 1 人心臟病發作。心臟生物標記在 ACS 診斷中發揮重要作用，有助於更快地做出治療決策。

在急性冠狀動脈症候群的風險分層和診斷中擴大採用生物標記正在推動需求。不健康的生活方式會增加急性冠狀動脈症候群和心肌梗塞的盛行率。 PoC 診斷的日益普及正在促進心臟標記的使用並推動細分市場的創新。醫院和 PoC 環境中採用心臟生物標記的範式轉變歸因於與心肌肌鈣蛋白 I 和心肌肌鈣蛋白 T 敏感性相關的檢測的最新進展。

此外，新型檢測方法的不斷增加是預計未來年度推動市場成長的關鍵因素之一。這正在推動新參與企業進入這一領域。例如，2021年5月，深圳邁瑞生物醫療電子宣布計畫以6.61億美元收購銷售心臟生物標記的公司HyTest。原料自家公司正成為企業確保原料穩定供應的首要領域。

心臟生物標記市場報告亮點

  • 按類型分類，肌鈣蛋白在 2022 年的銷售額中所佔佔有率最大，因為它經常用於心血管疾病的診斷。
  • 從應用來看，由於急性冠狀動脈症候群盛行率的增加以及生物標記在疾病診斷和治療中的應用不斷擴大，預計急性冠狀動脈領域將在預測期內以有利的速度成長。
  • 由於擁有發達的醫療保健系統，可以輕鬆採用心臟生物標記作為診斷和預後工具，北美將在 2022 年主導全球市場。
  • 預計亞太地區在預測期內將顯著成長。這是由於中國和日本等國家的目標人口廣泛，並且有大公司投資研發。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 心臟生物標記市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 心臟生物標記市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 心臟生物標記：類型估計/趨勢分析

  • 心臟生物標記市場：重點
  • 心臟生物標記市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 肌鈣蛋白
    • 2018年至2030年肌鈣蛋白市場估計與預測
  • CK-MB
    • 2018年至2030年CK-MB市場估計與預測
  • 肌紅蛋白
    • 2018年至2030年肌紅蛋白市場估計與預測
  • BNP 和 NT-proBNP
    • 2018年至2030年BNP和NT-proBNP市場估計和預測
  • 其他
    • 2018 年至 2030 年其他市場估計與預測

第5章 心臟生物標記：應用估計和趨勢分析

  • 心臟生物標記市場：重點
  • 心臟生物標記市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 急性冠狀動脈症候群
  • 心肌梗塞
  • 充血性心臟衰竭
  • 其他

第6章 心臟生物標記：最終用途估計和趨勢分析

  • 心臟生物標記市場：重點
  • 心臟生物標記市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 臨床檢查
    • 2018年至2030年臨床檢測市場估計與預測
  • 即時檢測
    • 2018 年至 2030 年即時檢測市場估計與預測

第7章 心臟生物標記市場：區域估計和趨勢分析

  • 區域展望
  • 按地區分類的心臟生物標記市場：要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Abbott
    • Quidel Corporation
    • Siemens Healthineers GmbH
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Randox Laboratories Ltd.
    • Creative Diagnostics
    • Life Diagnostics
Product Code: GVR-1-68038-083-5

Cardiac Biomarkers Market Growth & Trends:

The global cardiac biomarkers market size is expected to reach USD 47.88 billion by 2030, expanding at a CAGR of 14.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The increasing prevalence of acute coronary syndrome (ACS), along with advancements in biomarker technologies, is expected to propel market growth. The rising awareness regarding early diagnosis and prognosis of cardiac diseases is expected to further drive the market.

According to the NCBI, in 2021, in the U.S., over 15.5 million people were affected by coronary heart disease. Chest pain is one of the most common reasons for emergency department visits. Heart disease is one of the major causes of death in the U.S. and it is estimated that a person has a heart attack every 41 seconds. Cardiac biomarkers play a significant role in ACS diagnosis and facilitate faster treatment decision-making, thereby making them crucial.

The improving adoption of biomarkers in risk stratification and diagnosis of the acute coronary syndrome is impelling the demand. An unhealthy lifestyle is driving the prevalence of acute coronary syndrome and myocardial infarction. The increasing adoption of PoC diagnostics is driving segment innovation, making use of cardiac markers easier. The paradigm shift in the adoption of cardiac biomarkers in hospitals and PoC settings can be attributed to the recent developments in assays pertaining to the sensitivity of cardiac troponin I and cardiac troponin T.

Moreover, the rise in the availability of novel assays is one of the major drivers anticipated to boost market growth in the upcoming years. This is driving the movement of new players in the segment. For instance, in May 2021, Shenzhen Mindray Bio-Medical Electronics announced its plan to acquire HyTest, which is involved in cardiac biomarkers sales, for USD 661 million. In-house production of raw materials is becoming an area of prime focus for companies to ensure a steady flow of raw materials.

Cardiac Biomarkers Market Report Highlights:

  • By type, the troponin segment held the largest revenue share in 2022 owing to its high usage in cardiovascular diseases diagnosis
  • Based on application, the acute coronary syndrome segment is expected to grow at a lucrative rate during the forecast period due to the increasing prevalence of coronary diseases and expanding applications of these biomarkers in the diagnosis and treatment of diseases
  • North America dominated the global market in 2022 owing to the presence of a developed healthcare system that facilitates easier adoption of cardiac biomarkers as a tool for diagnosis and prognosis
  • Asia Pacific is expected to grow at a significant rate during the forecast period. This can be attributed to the presence of a wide target population and leading companies that are making R&D investments in countries such as China and Japan

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cardiac Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cardiac Biomarkers Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Cardiac Biomarkers: Type Estimates & Trend Analysis

  • 4.1. Cardiac Biomarkers Market: Key Takeaways
  • 4.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Troponin
    • 4.3.1. Troponin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. CK-MB
    • 4.4.1. CK-MB market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Myoglobin
    • 4.5.1. Myoglobin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. BNP and NT-proBNP
    • 4.6.1. BNP and NT-proBNP market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cardiac Biomarkers: Application Estimates & Trend Analysis

  • 5.1. Cardiac Biomarkers Market: Key Takeaways
  • 5.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Acute Coronary Syndrome
    • 5.3.1. Acute coronary syndrome market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Myocardial Infarction
    • 5.4.1. Myocardial infarction market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Congestive Heart Failure
    • 5.5.1. Congestive heart failure market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cardiac Biomarkers: End Use Estimates & Trend Analysis

  • 6.1. Cardiac Biomarkers Market: Key Takeaways
  • 6.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Laboratory Testing
    • 6.3.1. Laboratory testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Point of Care Testing
    • 6.4.1. Point of care testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cardiac Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Cardiac Biomarkers Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Quidel Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Siemens Healthineers GmbH
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. F. Hoffmann-La Roche Ltd.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Danaher
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. BIOMERIEUX
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Bio-Rad Laboratories, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Randox Laboratories Ltd.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Creative Diagnostics
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Life Diagnostics
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 23 France cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 24 France cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 48 China cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 49 China cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 51 India cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 52 India cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cardiac biomarkers: Market outlook
  • Fig. 8 Cardiac biomarkers: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Cardiac biomarkers market driver impact
  • Fig. 13 Cardiac biomarkers market restraint impact
  • Fig. 14 Cardiac biomarkers market strategic initiatives analysis
  • Fig. 15 Cardiac biomarkers market: Type movement analysis
  • Fig. 16 Cardiac biomarkers market: Type outlook and key takeaways
  • Fig. 17 Troponin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 CK-MB market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Myoglobin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 BNP and NT-proBNP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cardiac biomarkers market: Application movement analysis
  • Fig. 23 Cardiac biomarkers market: Application outlook and key takeaways
  • Fig. 24 Acute coronary syndrome market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Myocardial infarction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Congestive heart failure market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiac biomarkers market: End use movement analysis
  • Fig. 29 Cardiac biomarkers market: End use outlook and key takeaways
  • Fig. 30 Laboratory testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Point of care testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Pain management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Cancer therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Vaccine delivery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Global cardiac biomarkers market: Regional movement analysis
  • Fig. 37 Global cardiac biomarkers market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)